
Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy
Author(s) -
Teresa Bini,
Letizia Testa,
Elisabetta Chiesa,
Fulvio Adorni,
C. Abeli,
Barbara Castelnuovo,
Sara Melzi,
Salvatore Sollima,
Marco Bongiovanni,
Antonella d’Arminio Monforte
Publication year - 2000
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00042560-200006010-00005
Subject(s) - ritonavir , regimen , medicine , indinavir , protease inhibitor (pharmacology) , confidence interval , odds ratio , viral load , yesterday , antiretroviral therapy , human immunodeficiency virus (hiv) , family medicine , physics , astronomy